Sickness: From the focus on cytokines, prostaglandins, and complement factors to the perspectives of neurons

Neuroscience and Biobehavioral Reviews

Volumn 57, Issue , 2015, Pages 30-45

  Poon, David Chun Hei ^a   Ho, Yuen Shan ^c   Chiu, Kin ^a   Wong, Hoi Lam ^a   Chang, Raymond Chuen Chung ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

Complement factors; Cytokines; Depression; Neurohormones; Neuroinflammation; Prostaglandins; Sickness response; Systemic inflammation

Indexed keywords

ALPHA INTERFERON; C REACTIVE PROTEIN; C TYPE LECTIN RECEPTOR; COMPLEMENT COMPONENT C5A; COMPLEMENT FACTOR; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 3; CYTOKINE; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; NORADRENALIN; PROSTAGLANDIN; PROSTAGLANDIN E RECEPTOR 1; RECOMBINANT ALPHA INTERFERON; RECOMBINANT INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 1BETA; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; COMPLEMENT;

ANOREXIA; AREA POSTREMA; BLOOD BRAIN BARRIER; BODY RESPONSE; BODY SURFACE POTENTIAL; BRAIN; BRAIN FUNCTION; CHOROID PLEXUS; CIRCUMVENTRICULAR ORGAN; DELIRIUM; DEPRESSION; DIET RESTRICTION; DIGESTIVE SYSTEM CANCER; DISEASE SEVERITY; DISEASES; DRUG MEGADOSE; FATIGUE; FEVER; GENETIC CONSERVATION; HEADACHE; HEPATITIS; HUMAN; IMMOBILITY; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFECTION; INFLAMMATION; INJURY; INNATE IMMUNITY; MEDIAN EMINENCE; MOTIVATION; NATURAL KILLER CELL; NAUSEA; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OPTOGENETICS; ORGANUM VASCULOSUM OF THE LAMINA TERMINALIS; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PATTERN RECOGNITION; PHARMACOGENETICS; PREOPTIC AREA; PREOPTIC NUCLEUS; PRIORITY JOURNAL; PSYCHOSOCIAL WITHDRAWAL; REVIEW; RIGOR; SUPRAFORNICAL ORGAN; VOMITING; WEIGHT REDUCTION; ILLNESS BEHAVIOR; IMMUNOLOGY; NERVE CELL; PHYSIOLOGY;

BRAIN; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; HUMANS; ILLNESS BEHAVIOR; INFLAMMATION; NEURONS; PROSTAGLANDINS;

EID: 84940045554     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2015.07.015     Document Type: Review

References (262)

1. Akarasereenont P., Techatrisak K., Chotewuttakorn S., Thaworn A. The induction of cyclooxygenase-2 in IL-1beta-treated endothelial cells is inhibited by prostaglandin E2 through cAMP. Mediat. Inflamm. 1999, 8:287-294.
2. An Y., Chen Q., Quan N. Interleukin-1 exerts distinct actions on different cell types of the brain in vitro. J. Inflamm. Res. 2011, 11-20.
3. Aponte Y., Atasoy D., Sternson S.M. AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training. Nat. Neurosci. 2011, 14:351-355.
4. Aston-Jones G., Deisseroth K. Recent advances in optogenetics and pharmacogenetics. Brain Res. 2013, 1511:1-5.
5. Ballabh P., Braun A., Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol. Dis. 2004, 16:1-13.
6. Banks W.A., Ortiz L., Plotkin S.R., Kastin A.J. Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. J. Pharmacol. Exp. Ther. 1991, 259:988-996.
7. Banks W.A., Kastin A.J., Gutierrez E.G. Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci. Lett. 1994, 179:53-56.
8. Banks R.E., Forbes M.A., Storr M., Higginson J., Thompson D., Raynes J., Illingworth J.M., Perren T.J., Selby P.J., Whicher J.T. The acute phase protein response in patients receiving subcutaneous IL-6. Clin. Exp. Immunol. 1995, 102:217-223.
9. Banks W.A., Farr S.A., La Scola M.E., Morley J.E. Intravenous human interleukin-1alpha impairs memory processing in mice: dependence on blood-brain barrier transport into posterior division of the septum. J. Pharmacol. Exp. Ther. 2001, 299:536-541.
10. Bargmann C.I., Marder E. From the connectome to brain function. Nat. Methods 2013, 10:483-490.
11. Belladonna M.L., Grohmann U., Guidetti P., Volpi C., Bianchi R., Fioretti M.C., Schwarcz R., Fallarino F., Puccetti P. Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. J. Immunol. 2006, 177:130-137.
12. Belzung C., Turiault M., Griebel G. Optogenetics to study the circuits of fear- and depression-like behaviors: a critical analysis. Pharmacol. Biochem. Behav. 2014, 122:144-157.
13. Berk M., Wadee A.A., Kuschke R.H., O'Neill-Kerr A. Acute phase proteins in major depression. J. Psychosom. Res. 1997, 43:529-534.
14. Berkenbosch F., van Oers J., del Rey A., Tilders F., Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 1987, 238:524-526.
15. Betts J.C., Cheshire J.K., Akira S., Kishimoto T., Woo P. The role of NF-kappa B and NF-IL6 transactivating factors in the synergistic activation of human serum amyloid A gene expression by interleukin-1 and interleukin-6. J. Biol. Chem. 1993, 268:25624-25631.
16. Bianchi M.E. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 2007, 81:1-5.
17. Bilbo S.D., Schwarz J.M. The immune system and developmental programming of brain and behavior. Front. Neuroendocrinol. 2012, 33:267-286.
18. Blatteis C.M. Influence of body weight and temperature on the pyrogenic effect of endotoxin in guinea pigs. Toxicol. Appl. Pharmacol. 1974, 29:249-258.
19. Blatteis C.M. The onset of fever: new insights into its mechanism. Prog. Brain Res. 2007, 162:3-14.
20. Blatteis C.M., Li S., Li Z., Perlik V., Feleder C. Signaling the brain in systemic inflammation: the role of complement. Front. Biosci. 2004, 9:915-931.
21. Blatteis C.M., Li Z., Li S., Perlik V., Feleder C. Complement is required for the induction of endotoxic fever in guinea pigs and mice. J. Therm. Biol. 2004, 29:369-381.
22. Blatteis C.M., Li S., Li Z., Feleder C., Perlik V. Cytokines, PGE2 and endotoxic fever: a re-assessment. Prostaglandins Other Lipid Mediat. 2005, 76:1-18.
23. Bluthe R.M., Dantzer R., Kelley K.W. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Res. 1992, 573:318-320.
24. Bluthe R.M., Walter V., Parnet P., Laye S., Lestage J., Verrier D., Poole S., Stenning B.E., Kelley K.W., Dantzer R. Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism. C. R. Acad. Sci. Ser. III 1994, 317:499-503.
25. Bluthe R.M., Michaud B., Kelley K.W., Dantzer R. Vagotomy blocks behavioural effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes. Neuroreport 1996, 7:2823-2827.
26. Bluthe R.M., Laye S., Michaud B., Combe C., Dantzer R., Parnet P. Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice. Eur. J. Neurosci. 2000, 12:4447-4456.
27. Bluthe R.M., Michaud B., Poli V., Dantzer R. Role of IL-6 in cytokine-induced sickness behavior: a study with IL-6 deficient mice. Physiol. Behav. 2000, 70:367-373.
28. Bode J.G., Albrecht U., Haussinger D., Heinrich P.C., Schaper F. Hepatic acute phase proteins--regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-kappaB-dependent signaling. Eur. J. Cell Biol. 2012, 91:496-505.
29. Breder C.D., Dewitt D., Kraig R.P. Characterization of inducible cyclooxygenase in rat brain. J. Comp. Neurol. 1995, 355:296-315.
30. Cao C., Matsumura K., Yamagata K., Watanabe Y. Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1 beta: a possible site of prostaglandin synthesis responsible for fever. Brain Res. 1996, 733:263-272.
31. Cao C., Matsumura K., Shirakawa N., Maeda M., Jikihara I., Kobayashi S., Watanabe Y. Pyrogenic cytokines injected into the rat cerebral ventricle induce cyclooxygenase-2 in brain endothelial cells and also upregulate their receptors. Eur. J. Neurosci. 2001, 13:1781-1790.
32. Capuron L., Ravaud A. Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state. N. Engl. J. Med. 1999, 340:1370.
33. Capuron L., Gumnick J.F., Musselman D.L., Lawson D.H., Reemsnyder A., Nemeroff C.B., Miller A.H. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 2002, 26:643-652.
34. Capuron L., Neurauter G., Musselman D.L., Lawson D.H., Nemeroff C.B., Fuchs D., Miller A.H. Interferon-alpha-induced changes in tryptophan metabolism. Relationship to depression and paroxetine treatment. Biol. Psychiatry 2003, 54:906-914.
35. Capuron L., Raison C.L., Musselman D.L., Lawson D.H., Nemeroff C.B., Miller A.H. Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am. J. Psychiatry 2003, 160:1342-1345.
36. Catania A., Suffredini A.F., Lipton J.M. Endotoxin causes release of alpha-melanocyte-stimulating hormone in normal human subjects. Neuroimmunomodulation 1995, 2:258-262.
37. Chang R.C., Chiu K., Ho Y.S., So K.F. Modulation of neuroimmune responses on glia in the central nervous system: implication in therapeutic intervention against neuroinflammation. Cell. Mol. Immunol. 2009, 6:317-326.
38. Chen C., Bazan N.G. Endogenous PGE2 regulates membrane excitability and synaptic transmission in hippocampal CA1 pyramidal neurons. J. Neurophysiol. 2005, 93:929-941.
39. Chen G.Y., Nunez G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 2010, 10:826-837.
40. Chen C., Magee J.C., Bazan N.G. Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity. J. Neurophysiol. 2002, 87:2851-2857.
41. Chiarugi A., Calvani M., Meli E., Traggiai E., Moroni F. Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages. J. Neuroimmunol. 2001, 120:190-198.
42. Crown J., Jakubowski A., Kemeny N., Gordon M., Gasparetto C., Wong G., Sheridan C., Toner G., Meisenberg B., Botet J., et al. A phase I trial of recombinant human interleukin-1 beta alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer. Blood 1991, 78:1420-1427.
43. Cunningham C., Maclullich A.M. At the extreme end of the psychoneuroimmunological spectrum: delirium as a maladaptive sickness behaviour response. Brain Behav. Immun. 2012, 28:1-13.
44. Cunningham C., Wilcockson D.C., Campion S., Lunnon K., Perry V.H. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J. Neurosci. 2005, 25:9275-9284.
45. Cunningham C., Campion S., Teeling J., Felton L., Perry V.H. The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C). Brain Behav. Immun. 2007, 21:490-502.
46. Cunningham C., Campion S., Lunnon K., Murray C.L., Woods J.F., Deacon R.M., Rawlins J.N., Perry V.H. Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol. Psychiatry 2009, 65:304-312.
47. Czapski G.A., Gajkowska B., Strosznajder J.B. Systemic administration of lipopolysaccharide induces molecular and morphological alterations in the hippocampus. Brain Res. 2010, 1356:85-94.
48. Dai C., Deng Y., Quinlan A., Gaskin F., Tsao B.P., Fu S.M. Genetics of systemic lupus erythematosus: immune responses and end organ resistance to damage. Curr. Opin. Immunol. 2014, 31C:87-96.
49. Dallaporta M., Pecchi E., Jacques C., Berenbaum F., Jean A., Thirion S., Troadec J.D. c-Fos immunoreactivity induced by intraperitoneal LPS administration is reduced in the brain of mice lacking the microsomal prostaglandin E synthase-1 (mPGES-1). Brain Behav. Immun. 2007, 21:1109-1121.
50. Dantzer R. Cytokine-induced sickness behavior: where do we stand?. Brain Behav. Immun. 2001, 15:7-24.
51. Dantzer R. Cytokine, sickness behavior, and depression. Immunol. Allergy Clin. N. Am. 2009, 29:247-264.
52. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
53. Deacon R.M. Burrowing in rodents: a sensitive method for detecting behavioral dysfunction. Nat. Protoc. 2006, 1:118-121.
54. Deacon R.M., Croucher A., Rawlins J.N. Hippocampal cytotoxic lesion effects on species-typical behaviours in mice. Behav. Brain Res. 2002, 132:203-213.
55. D'Mello C., Le T., Swain M.G. Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation. J. Neurosci. 2009, 29:2089-2102.
56. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., Lanctot K.L. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67:446-457.
57. Dunn A.J., Swiergiel A.H. The role of cyclooxygenases in endotoxin- and interleukin-1-induced hypophagia. Brain Behav. Immun. 2000, 14:141-152.
58. Dyrna F., Hanske S., Krueger M., Bechmann I. The blood-brain barrier. J. Neuroimmune Pharmacol. 2013, 8:763-773.
59. Eisenberger N.I., Berkman E.T., Inagaki T.K., Rameson L.T., Mashal N.M., Irwin M.R. Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol. Psychiatry 2010, 68:748-754.
60. Ek M., Kurosawa M., Lundeberg T., Ericsson A. Activation of vagal afferents after intravenous injection of interleukin-1beta: role of endogenous prostaglandins. J. Neurosci. 1998, 18:9471-9479.
61. Eliopoulos A.G., Dumitru C.D., Wang C.C., Cho J., Tsichlis P.N. Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals. EMBO J. 2002, 21:4831-4840.
62. Engblom D., Saha S., Engstrom L., Westman M., Audoly L.P., Jakobsson P.J., Blomqvist A. Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis. Nat. Neurosci. 2003, 6:1137-1138.
63. Eriksson C., Nobel S., Winblad B., Schultzberg M. Expression of interleukin 1 alpha and beta, and interleukin 1 receptor antagonist mRNA in the rat central nervous system after peripheral administration of lipopolysaccharides. Cytokine 2000, 12:423-431.
64. Esser N., Legrand-Poels S., Piette J., Scheen A.J., Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res. Clin. Pract. 2014, 105:141-150.
65. Fabry Z., Fitzsimmons K.M., Herlein J.A., Moninger T.O., Dobbs M.B., Hart M.N. Production of the cytokines interleukin 1 and 6 by murine brain microvessel endothelium and smooth muscle pericytes. J. Neuroimmunol. 1993, 47:23-34.
66. Feleder C., Perlik V., Blatteis C.M. Preoptic alpha 1- and alpha 2-noradrenergic agonists induce, respectively, PGE2-independent and PGE2-dependent hyperthermic responses in guinea pigs. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 286:R1156-R1166.
67. Feleder C., Perlik V., Blatteis C.M. Preoptic norepinephrine mediates the febrile response of guinea pigs to lipopolysaccharide. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293:R1135-R1143.
68. Ferguson S.M., Neumaier J.F. Grateful DREADDs: engineered receptors reveal how neural circuits regulate behavior. Neuropsychopharmacology 2012, 37:296-297.
69. Fernandez-Martinez E., Perez-Alvarez V., Tsutsumi V., Shibayama M., Muriel P. Chronic bile duct obstruction induces changes in plasma and hepatic levels of cytokines and nitric oxide in the rat. Exp. Toxicol. Pathol. 2006, 58:49-58.
70. Field R., Campion S., Warren C., Murray C., Cunningham C. Systemic challenge with the TLR3 agonist poly I:C induces amplified IFNalpha/beta and IL-1beta responses in the diseased brain and exacerbates chronic neurodegeneration. Brain Behav. Immun. 2010, 24:996-1007.
71. Font-Nieves M., Sans-Fons M.G., Gorina R., Bonfill-Teixidor E., Salas-Perdomo A., Marquez-Kisinousky L., Santalucia T., Planas A.M. Induction of COX-2 enzyme and down-regulation of COX-1 expression by lipopolysaccharide (LPS) control prostaglandin E2 production in astrocytes. J. Biol. Chem. 2012, 287:6454-6468.
72. Frenois F., Moreau M., O'Connor J., Lawson M., Micon C., Lestage J., Kelley K.W., Dantzer R., Castanon N. Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 2007, 32:516-531.
73. Friebe A., Horn M., Schmidt F., Janssen G., Schmid-Wendtner M.H., Volkenandt M., Hauschild A., Goldsmith C.H., Schaefer M. Dose-dependent development of depressive symptoms during adjuvant interferon-{alpha} treatment of patients with malignant melanoma. Psychosomatics 2010, 51:466-473.
74. Furuyashiki T., Narumiya S. Stress responses: the contribution of prostaglandin E(2) and its receptors. Nat. Rev. Endocrinol. 2011, 7:163-175.
75. Gautron L., Laye S. Neurobiology of inflammation-associated anorexia. Front. Neurosci. 2009, 3:59.
76. Gaykema R.P., Goehler L.E. Lipopolysaccharide challenge-induced suppression of Fos in hypothalamic orexin neurons: their potential role in sickness behavior. Brain Behav. Immun. 2009, 23:926-930.
77. Gaykema R.P., Goehler L.E. Ascending caudal medullary catecholamine pathways drive sickness-induced deficits in exploratory behavior: brain substrates for fatigue?. Brain Behav. Immun. 2011, 25:443-460.
78. Glass C.K., Saijo K., Winner B., Marchetto M.C., Gage F.H. Mechanisms underlying inflammation in neurodegeneration. Cell 2010, 140:918-934.
79. Glocker E.O., Kotlarz D., Klein C., Shah N., Grimbacher B. IL-10 and IL-10 receptor defects in humans. Ann. N. Y. Acad. Sci. 2011, 1246:102-107.
80. Goebel M., Stengel A., Wang L., Reeve J., Tache Y. Lipopolysaccharide increases plasma levels of corticotropin-releasing hormone in rats. Neuroendocrinology 2011, 93:165-173.
81. Griffin E.W., Skelly D.T., Murray C.L., Cunningham C. Cyclooxygenase-1-dependent prostaglandins mediate susceptibility to systemic inflammation-induced acute cognitive dysfunction. J. Neurosci. 2013, 33:15248-15258.
82. Grossberg A.J., Zhu X., Leinninger G.M., Levasseur P.R., Braun T.P., Myers M.G., Marks D.L. Inflammation-induced lethargy is mediated by suppression of orexin neuron activity. J. Neurosci. 2011, 31:11376-11386.
83. Guillemin G.J., Smith D.G., Smythe G.A., Armati P.J., Brew B.J. Expression of the kynurenine pathway enzymes in human microglia and macrophages. Adv. Exp. Med. Biol. 2003, 527:105-112.
84. Gutierrez E.G., Banks W.A., Kastin A.J. Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrier. J. Neuroimmunol. 1994, 55:153-160.
85. Hannestad J., DellaGioia N., Ortiz N., Pittman B., Bhagwagar Z. Citalopram reduces endotoxin-induced fatigue. Brain Behav. Immun. 2011, 25:256-259.
86. Hansen M.K., Taishi P., Chen Z., Krueger J.M. Vagotomy blocks the induction of interleukin-1beta (IL-1beta) mRNA in the brain of rats in response to systemic IL-1beta. J. Neurosci. 1998, 18:2247-2253.
87. Hansen M.K., O'Connor K.A., Goehler L.E., Watkins L.R., Maier S.F. The contribution of the vagus nerve in interleukin-1β-induced fever is dependent on dose. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 280:R929-R934.
88. Harden L.M., du Plessis I., Poole S., Laburn H.P. Interleukin-6 and leptin mediate lipopolysaccharide-induced fever and sickness behavior. Physiol. Behav. 2006, 89:146-155.
89. Harden L.M., du Plessis I., Poole S., Laburn H.P. Interleukin (IL)-6 and IL-1 beta act synergistically within the brain to induce sickness behavior and fever in rats. Brain Behav. Immun. 2008, 22:838-849.
90. Harrison N.A., Doeller C.F., Voon V., Burgess N., Critchley H.D. Peripheral inflammation acutely impairs human spatial memory via actions on medial temporal lobe glucose metabolism. Biol. Psychiatry 2014, 76:585-593.
91. Hart B.L. Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 1988, 12:123-137.
92. Hein A.M., O'Banion M.K. Neuroinflammation and memory: the role of prostaglandins. Mol. Neurobiol. 2009, 40:15-32.
93. Hein A.M., Stutzman D.L., Bland S.T., Barrientos R.M., Watkins L.R., Rudy J.W., Maier S.F. Prostaglandins are necessary and sufficient to induce contextual fear learning impairments after interleukin-1 beta injections into the dorsal hippocampus. Neuroscience 2007, 150:754-763.
94. Henry C.J., Huang Y., Wynne A., Hanke M., Himler J., Bailey M.T., Sheridan J.F., Godbout J.P. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J. Neuroinflamm. 2008, 5:15.
95. Heydendael W., Sengupta A., Beck S., Bhatnagar S. Optogenetic examination identifies a context-specific role for orexins/hypocretins in anxiety-related behavior. Physiol. Behav. 2014, 130:182-190.
96. Hiles S.A., Baker A.L., de Malmanche T., Attia J. A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: exploring the causes of heterogeneity. Brain Behav. Immun. 2012, 26:1180-1188.
97. Hosoi T., Okuma Y., Nomura Y. Electrical stimulation of afferent vagus nerve induces IL-1beta expression in the brain and activates HPA axis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 279:R141-R147.
98. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 2009, 71:171-186.
99. Hsieh C.H., Li H.Y., Chen J.C. Nitric oxide and interleukin-1beta mediate noradrenergic induced corticotrophin-releasing hormone release in organotypic cultures of rat paraventricular nucleus. Neuroscience 2010, 165:1191-1202.
100. Huang Q.H., Hruby V.J., Tatro J.B. Role of central melanocortins in endotoxin-induced anorexia. Am. J. Physiol. 1999, 276:R864-R871.
101. Huang Y., Henry C.J., Dantzer R., Johnson R.W., Godbout J.P. Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide. Neurobiol. Aging 2008, 29:1744-1753.
102. Inagaki T.K., Muscatell K.A., Irwin M.R., Cole S.W., Eisenberger N.I. Inflammation selectively enhances amygdala activity to socially threatening images. Neuroimage 2012, 59:3222-3226.
103. Ivanov A.I., Pero R.S., Scheck A.C., Romanovsky A.A. Prostaglandin E(2)-synthesizing enzymes in fever: differential transcriptional regulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 283:R1104-R1117.
104. Jain N.K., Patil C.S., Kulkarni S.K., Singh A. Modulatory role of cyclooxygenase inhibitors in aging- and scopolamine or lipopolysaccharide-induced cognitive dysfunction in mice. Behav. Brain Res. 2002, 133:369-376.
105. Jansky L., Vybiral S., Pospisilova D., Roth J., Dornand J., Zeisberger E., Kaminkova J. Production of systemic and hypothalamic cytokines during the early phase of endotoxin fever. Neuroendocrinology 1995, 62:55-61.
106. Johnson P.M., Vogt S.K., Burney M.W., Muglia L.J. COX-2 inhibition attenuates anorexia during systemic inflammation without impairing cytokine production. Am. J. Physiol. Endocrinol. Metab. 2002, 282:E650-E656.
107. Kakucska I., Qi Y., Clark B.D., Lechan R.M. Endotoxin-induced corticotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is mediated centrally by interleukin-1. Endocrinology 1993, 133:815-821.
108. Kawai T., Akira S. Toll-like receptor and RIG-I-like receptor signaling. Ann. N. Y. Acad. Sci. 2008, 1143:1-20.
109. Kawai T., Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int. Immunol. 2009, 21:317-337.
110. Kelso A. Cytokines: principles and prospects. Immunol. Cell Biol. 1998, 76:300-317.
111. Kemna E., Pickkers P., Nemeth E., van der Hoeven H., Swinkels D. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 2005, 106:1864-1866.
112. Kent S., Bluthe R.M., Dantzer R., Hardwick A.J., Kelley K.W., Rothwell N.J., Vannice J.L. Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:9117-9120.
113. Kettenmann H., Hanisch U.K., Noda M., Verkhratsky A. Physiology of microglia. Physiol. Rev. 2011, 91:461-553.
114. Kirby E.D., Jensen K., Goosens K.A., Kaufer D. Stereotaxic surgery for excitotoxic lesion of specific brain areas in the adult rat. J. Vis. Exp.: JoVE 2012, e4079.
115. Kis B., Snipes J.A., Gaspar T., Lenzser G., Tulbert C.D., Busija D.W. Cloning of cyclooxygenase-1b (putative COX-3) in mouse. Inflamm. Res. 2006, 55:274-278.
116. Kivimaki M., Shipley M.J., Batty G.D., Hamer M., Akbaraly T.N., Kumari M., Jokela M., Virtanen M., Lowe G.D., Ebmeier K.P., Brunner E.J., Singh-Manoux A. Long-term inflammation increases risk of common mental disorder: a cohort study. Mol. Psychiatry 2014, 19:149-150.
117. Konat G.W., Borysiewicz E., Fil D., James I. Peripheral challenge with double-stranded RNA elicits global up-regulation of cytokine gene expression in the brain. J. Neurosci. Res. 2009, 87:1381-1388.
118. Konsman J.P., Luheshi G.N., Bluthe R.M., Dantzer R. The vagus nerve mediates behavioural depression, but not fever, in response to peripheral immune signals; a functional anatomical analysis. Eur. J. Neurosci. 2000, 12:4434-4446.
119. Konsman J.P., Vigues S., Mackerlova L., Bristow A., Blomqvist A. Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli. J. Comp. Neurol. 2004, 472:113-129.
120. Konsman J.P., Veeneman J., Combe C., Poole S., Luheshi G.N., Dantzer R. Central nervous action of interleukin-1 mediates activation of limbic structures and behavioural depression in response to peripheral administration of bacterial lipopolysaccharide. Eur. J. Neurosci. 2008, 28:2499-2510.
121. Kozak W., Poli V., Soszynski D., Conn C.A., Leon L.R., Kluger M.J. Sickness behavior in mice deficient in interleukin-6 during turpentine abscess and influenza pneumonitis. Am. J. Physiol. 1997, 272:R621-R630.
122. Kozlowski C., Weimer R.M. An automated method to quantify microglia morphology and application to monitor activation state longitudinally in vivo. PLoS ONE 2012, 7:e31814.
123. Krashes M.J., Koda S., Ye C., Rogan S.C., Adams A.C., Cusher D.S., Maratos-Flier E., Roth B.L., Lowell B.B. Rapid, reversible activation of AgRP neurons drives feeding behavior in mice. J. Clin. Investig. 2011, 121:1424-1428.
124. Kraus M.R., Al-Taie O., Schafer A., Pfersdorff M., Lesch K.P., Scheurlen M. Serotonin-1A receptor gene HTR1A variation predicts interferon-induced depression in chronic hepatitis C. Gastroenterology 2007, 132:1279-1286.
125. Lawrence C.B., Rothwell N.J. Anorexic but not pyrogenic actions of interleukin-1 are modulated by central melanocortin-3/4 receptors in the rat. J. Neuroendocrinol. 2001, 13:490-495.
126. Laye S., Bluthe R.M., Kent S., Combe C., Medina C., Parnet P., Kelley K., Dantzer R. Subdiaphragmatic vagotomy blocks induction of IL-1 beta mRNA in mice brain in response to peripheral LPS. Am. J. Physiol. 1995, 268:R1327-R1331.
127. Laye S., Gheusi G., Cremona S., Combe C., Kelley K., Dantzer R., Parnet P. Endogenous brain IL-1 mediates LPS-induced anorexia and hypothalamic cytokine expression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 279:R93-R98.
128. Lazarus M., Yoshida K., Coppari R., Bass C.E., Mochizuki T., Lowell B.B., Saper C.B. EP3 prostaglandin receptors in the median preoptic nucleus are critical for fever responses. Nat. Neurosci. 2007, 10:1131-1133.
129. Lee M.S., Kim Y.J. Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu. Rev. Biochem. 2007, 76:447-480.
130. Leon L.R., Kozak W., Rudolph K., Kluger M.J. An antipyretic role for interleukin-10 in LPS fever in mice. Am. J. Physiol. 1999, 276:R81-R89.
131. Li S., Ballou L.R., Morham S.G., Blatteis C.M. Cyclooxygenase-2 mediates the febrile response of mice to interleukin-1beta. Brain Res. 2001, 910:163-173.
132. Li S., Wang Y., Matsumura K., Ballou L.R., Morham S.G., Blatteis C.M. The febrile response to lipopolysaccharide is blocked in cyclooxygenase-2(-/-), but not in cyclooxygenase-1(-/-) mice. Brain Res. 1999, 825:86-94.
133. Li Z., Blatteis C.M. Fever onset is linked to the appearance of lipopolysaccharide in the liver. J. Endotoxin Res. 2004, 10:39-53.
134. Li S., Holers V.M., Boackle S.A., Blatteis C.M. Modulation of mouse endotoxic fever by complement. Infect. Immun. 2002, 70:2519-2525.
135. Li S., Boackle S.A., Holers V.M., Lambris J.D., Blatteis C.M. Complement component c5a is integral to the febrile response of mice to lipopolysaccharide. Neuroimmunomodulation 2005, 12:67-80.
136. Li Z., Perlik V., Feleder C., Tang Y., Blatteis C.M. Kupffer cell-generated PGE2 triggers the febrile response of guinea pigs to intravenously injected LPS. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 290:R1262-R1270.
137. Liu F., Gu J. Retinoic acid inducible gene-I, more than a virus sensor. Protein Cell 2011, 2:351-357.
138. Lu Y.C., Yeh W.C., Ohashi P.S. LPS/TLR4 signal transduction pathway. Cytokine 2008, 42:145-151.
139. Luheshi G., Miller A.J., Brouwer S., Dascombe M.J., Rothwell N.J., Hopkins S.J. Interleukin-1 receptor antagonist inhibits endotoxin fever and systemic interleukin-6 induction in the rat. Am. J. Physiol. 1996, 270:E91-E95.
140. Lund S., Christensen K.V., Hedtjarn M., Mortensen A.L., Hagberg H., Falsig J., Hasseldam H., Schrattenholz A., Porzgen P., Leist M. The dynamics of the LPS triggered inflammatory response of murine microglia under different culture and in vivo conditions. J. Neuroimmunol. 2006, 180:71-87.
141. Maes M., Berk M., Goehler L., Song C., Anderson G., Galecki P., Leonard B. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med. 2012, 10:66.
142. Mangge H., Becker K., Fuchs D., Gostner J.M. Antioxidants, inflammation and cardiovascular disease. World J. Cardiol. 2014, 6:462-477.
143. Mark K.S., Trickler W.J., Miller D.W. Tumor necrosis factor-alpha induces cyclooxygenase-2 expression and prostaglandin release in brain microvessel endothelial cells. J. Pharmacol. Exp. Ther. 2001, 297:1051-1058.
144. Martin L.W., Lipton J.M. Acute phase response to endotoxin: rise in plasma alpha-MSH and effects of alpha-MSH injection. Am. J. Physiol. 1990, 259:R768-R772.
145. Marvel F.A., Chen C.C., Badr N., Gaykema R.P., Goehler L.E. Reversible inactivation of the dorsal vagal complex blocks lipopolysaccharide-induced social withdrawal and c-Fos expression in central autonomic nuclei. Brain Behav. Immun. 2004, 18:123-134.
146. Matousek S.B., Hein A.M., Shaftel S.S., Olschowka J.A., Kyrkanides S., O'Banion M.K. Cyclooxygenase-1 mediates prostaglandin E(2) elevation and contextual memory impairment in a model of sustained hippocampal interleukin-1beta expression. J. Neurochem. 2010, 114:247-258.
147. Matsumoto M., Seya T. TLR3: interferon induction by double-stranded RNA including poly(I:C). Adv. Drug Deliv. Rev. 2008, 60:805-812.
148. Matsumura K., Cao C., Ozaki M., Morii H., Nakadate K., Watanabe Y. Brain endothelial cells express cyclooxygenase-2 during lipopolysaccharide-induced fever: light and electron microscopic immunocytochemical studies. J. Neurosci. 1998, 18:6279-6289.
149. Matsunaga W., Miyata S., Takamata A., Bun H., Nakashima T., Kiyohara T. LPS-induced Fos expression in oxytocin and vasopressin neurons of the rat hypothalamus. Brain Res. 2000, 858:9-18.
150. Matsuoka Y., Furuyashiki T., Bito H., Ushikubi F., Tanaka Y., Kobayashi T., Muro S., Satoh N., Kayahara T., Higashi M., Mizoguchi A., Shichi H., Fukuda Y., Nakao K., Narumiya S. Impaired adrenocorticotropic hormone response to bacterial endotoxin in mice deficient in prostaglandin E receptor EP1 and EP3 subtypes. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:4132-4137.
151. Montuschi P., Barnes P.J., Roberts L.J. Isoprostanes: markers and mediators of oxidative stress. FASEB J. 2004, 18:1791-1800.
152. Muller N., Schwarz M.J., Dehning S., Douhe A., Cerovecki A., Goldstein-Muller B., Spellmann I., Hetzel G., Maino K., Kleindienst N., Moller H.J., Arolt V., Riedel M. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol. Psychiatry 2006, 11:680-684.
153. Mullington J., Korth C., Hermann D.M., Orth A., Galanos C., Holsboer F., Pollmacher T. Dose-dependent effects of endotoxin on human sleep. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 278:R947-R955.
154. Murray C.L., Skelly D.T., Cunningham C. Exacerbation of CNS inflammation and neurodegeneration by systemic LPS treatment is independent of circulating IL-1beta and IL-6. J. Neuroinflamm. 2011, 8:50.
155. Murray C., Sanderson D.J., Barkus C., Deacon R.M., Rawlins J.N., Bannerman D.M., Cunningham C. Systemic inflammation induces acute working memory deficits in the primed brain: relevance for delirium. Neurobiol. Aging 2012, 33. 603-616.e603.
156. Nakamura K. Central circuitries for body temperature regulation and fever. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 301:R1207-R1228.
157. Nakamura K., Matsumura K., Kaneko T., Kobayashi S., Katoh H., Negishi M. The rostral raphe pallidus nucleus mediates pyrogenic transmission from the preoptic area. J. Neurosci. 2002, 22:4600-4610.
158. Nakamura Y., Nakamura K., Matsumura K., Kobayashi S., Kaneko T., Morrison S.F. Direct pyrogenic input from prostaglandin EP3 receptor-expressing preoptic neurons to the dorsomedial hypothalamus. Eur. J. Neurosci. 2005, 22:3137-3146.
159. Nakamura Y., Nakamura K., Morrison S.F. Different populations of prostaglandin EP3 receptor-expressing preoptic neurons project to two fever-mediating sympathoexcitatory brain regions. Neuroscience 2009, 161:614-620.
160. Narumiya S., Sugimoto Y., Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 1999, 79:1193-1226.
161. Obuchowicz E., Bielecka A.M., Paul-Samojedny M., Pudelko A., Kowalski J. Imipramine and fluoxetine inhibit LPS-induced activation and affect morphology of microglial cells in the rat glial culture. Pharmacol. Rep. 2014, 66:34-43.
162. O'Connor J.C., Andre C., Wang Y., Lawson M.A., Szegedi S.S., Lestage J., Castanon N., Kelley K.W., Dantzer R. Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J. Neurosci. 2009, 29:4200-4209.
163. O'Connor J.C., Lawson M.A., Andre C., Moreau M., Lestage J., Castanon N., Kelley K.W., Dantzer R. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol. Psychiatry 2009, 14:511-522.
164. Ohinata K., Suetsugu K., Fujiwara Y., Yoshikawa M. Activation of prostaglandin E receptor EP4 subtype suppresses food intake in mice. Prostaglandins Other Lipid Mediat. 2006, 81:31-36.
165. Osburg B., Peiser C., Domling D., Schomburg L., Ko Y.T., Voigt K., Bickel U. Effect of endotoxin on expression of TNF receptors and transport of TNF-alpha at the blood-brain barrier of the rat. Am. J. Physiol. Endocrinol. Metab. 2002, 283:E899-E908.
166. Osorio F., Reis e Sousa C. Myeloid C-type lectin receptors in pathogen recognition and host defense. Immunity 2011, 34:651-664.
167. Ott D., Wuchert F., Murgott J., Rummel C., Gerstberger R., Roth J. The viral mimetic polyinosinic:polycytidylic acid (poly I:C) induces cellular responses in primary cultures from rat brain sites with an incomplete blood-brain barrier. Neurosci. Lett. 2012, 530:64-68.
168. Oxenkrug G., Perianayagam M., Mikolich D., Requintina P., Shick L., Ruthazer R., Zucker D., Summergrad P. Interferon-gamma (+874) T/A genotypes and risk of IFN-alpha-induced depression. J. Neural Transm. 2011, 118:271-274.
169. Palin K., Bluthe R.M., McCusker R.H., Moos F., Dantzer R., Kelley K.W. TNFalpha-induced sickness behavior in mice with functional 55kD TNF receptors is blocked by central IGF-I. J. Neuroimmunol. 2007, 187:55-60.
170. Palin K., McCusker R.H., Strle K., Moos F., Dantzer R., Kelley K.W. Tumor necrosis factor-alpha-induced sickness behavior is impaired by central administration of an inhibitor of c-jun N-terminal kinase. Psychopharmacology (Berl.) 2008, 197:629-635.
171. Palin K., Bluthe R.M., McCusker R.H., Levade T., Moos F., Dantzer R., Kelley K.W. The type 1 TNF receptor and its associated adapter protein, FAN, are required for TNFalpha-induced sickness behavior. Psychopharmacology (Berl.) 2009, 201:549-556.
172. Park J.S., Gamboni-Robertson F., He Q., Svetkauskaite D., Kim J.Y., Strassheim D., Sohn J.W., Yamada S., Maruyama I., Banerjee A., Ishizaka A., Abraham E. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am. J. Physiol. Cell Physiol. 2006, 290:C917-C924.
173. Park J.Y., Pillinger M.H., Abramson S.B. Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clin. Immunol. 2006, 119:229-240.
174. Parrott R.F., Vellucci S.V. Effects of testosterone on fever and vasopressin mRNA in wether sheep given endotoxin. Res. Vet. Sci. 1997, 63:129-131.
175. Pecchi E., Dallaporta M., Thirion S., Salvat C., Berenbaum F., Jean A., Troadec J.D. Involvement of central microsomal prostaglandin E synthase-1 in IL-1beta-induced anorexia. Physiol. Genomics 2006, 25:485-492.
176. Perlik V., Li Z., Goorha S., Ballou L.R., Blatteis C.M. LPS-activated complement, not LPS per se, triggers the early release of PGE2 by Kupffer cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289:R332-R339.
177. Perry V.H. Contribution of systemic inflammation to chronic neurodegeneration. Acta Neuropathol. (Berl.) 2010, 120:277-286.
178. Petersen L.J., Zacho H.D., Lyngholm A.M., Arendt-Nielsen L. Tissue viability imaging for assessment of pharmacologically induced vasodilation and vasoconstriction in human skin. Microvasc. Res. 2010, 80:499-504.
179. Poon D.C., Ho Y.S., Chiu K., Chang R.C. Cytokines: how important are they in mediating sickness?. Neurosci. Biobehav. Rev. 2013, 37:1-10.
180. Porreca E., Reale M., Di Febbo C., Di Gioacchino M., Barbacane R.C., Castellani M.L., Baccante G., Conti P., Cuccurullo F. Down-regulation of cyclooxygenase-2 (COX-2) by interleukin-1 receptor antagonist in human monocytes. Immunology 1996, 89:424-429.
181. Pruimboom W.M., van Dijk J.A., Tak C.J., Garrelds I., Bonta I.L., Wilson P.J., Zijlstra F.J. Interactions between cytokines and eicosanoids: a study using human peritoneal macrophages. Immunol. Lett. 1994, 41:255-260.
182. Quan N., Whiteside M., Herkenham M. Time course and localization patterns of interleukin-1beta messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience 1998, 83:281-293.
183. Renault P.F., Hoofnagle J.H., Park Y., Mullen K.D., Peters M., Jones D.B., Rustgi V., Jones E.A. Psychiatric complications of long-term interferon alfa therapy. Arch. Intern. Med. 1987, 147:1577-1580.
184. Richwine A.F., Sparkman N.L., Dilger R.N., Buchanan J.B., Johnson R.W. Cognitive deficits in interleukin-10-deficient mice after peripheral injection of lipopolysaccharide. Brain Behav. Immun. 2009, 23:794-802.
185. Rivest S., Laflamme N. Neuronal activity and neuropeptide gene transcription in the brains of immune-challenged rats. J. Neuroendocrinol. 1995, 7:501-525.
186. Romanovsky A.A., Simons C.T., Szekely M., Kulchitsky V.A. The vagus nerve in the thermoregulatory response to systemic inflammation. Am. J. Physiol. 1997, 273:R407-R413.
187. Romeo H.E., Tio D.L., Rahman S.U., Chiappelli F., Taylor A.N. The glossopharyngeal nerve as a novel pathway in immune-to-brain communication: relevance to neuroimmune surveillance of the oral cavity. J. Neuroimmunol. 2001, 115:91-100.
188. Rorato R., Castro M., Borges B.C., Benedetti M., Germano C.M., Antunes-Rodrigues J., Elias L.L. Adrenalectomy enhances endotoxemia-induced hypophagia: higher activation of corticotrophin-releasing-factor and proopiomelanocortin hypothalamic neurons. Horm. Behav. 2008, 54:134-142.
189. Rorato R., Menezes A.M., Giusti-Paiva A., de Castro M., Antunes-Rodrigues J., Elias L.L. Prostaglandin mediates endotoxaemia-induced hypophagia by activation of pro-opiomelanocortin and corticotrophin-releasing factor neurons in rats. Exp. Physiol. 2009, 94:371-379.
190. Rosenthal M.J., Morley J.E. Corticotropin releasing factor (CRF) and age-related differences in behavior of mice. Neurobiol. Aging 1989, 10:167-171.
191. Rosin D.L., Okusa M.D. Dangers within: DAMP responses to damage and cell death in kidney disease. J. Am. Soc. Nephrol. 2011, 22:416-425.
192. Rother E., Belgardt B.F., Tsaousidou E., Hampel B., Waisman A., Myers M.G., Bruning J.C. Acute selective ablation of rat insulin promoter-expressing (RIPHER) neurons defines their orexigenic nature. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:18132-18137.
193. Rudaya A.Y., Steiner A.A., Robbins J.R., Dragic A.S., Romanovsky A.A. Thermoregulatory responses to lipopolysaccharide in the mouse: dependence on the dose and ambient temperature. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289:R1244-R1252.
194. Sadeghi S., Wallace F.A., Calder P.C. Dietary lipids modify the cytokine response to bacterial lipopolysaccharide in mice. Immunology 1999, 96:404-410.
195. Sagar S.M., Price K.J., Kasting N.W., Sharp F.R. Anatomic patterns of Fos immunostaining in rat brain following systemic endotoxin administration. Brain Res. Bull. 1995, 36:381-392.
196. Saleh M. The machinery of Nod-like receptors: refining the paths to immunity and cell death. Immunol. Rev. 2011, 243:235-246.
197. Sang N., Zhang J., Marcheselli V., Bazan N.G., Chen C. Postsynaptically synthesized prostaglandin E2 (PGE2) modulates hippocampal synaptic transmission via a presynaptic PGE2 EP2 receptor. J. Neurosci. 2005, 25:9858-9870.
198. Saper C.B., Romanovsky A.A., Scammell T.E. Neural circuitry engaged by prostaglandins during the sickness syndrome. Nat. Neurosci. 2012, 15:1088-1095.
199. Sarma J.V., Ward P.A. The complement system. Cell Tissue Res. 2011, 343:227-235.
200. Sartin J.L., Marks D.L., McMahon C.D., Daniel J.A., Levasseur P., Wagner C.G., Whitlock B.K., Steele B.P. Central role of the melanocortin-4 receptors in appetite regulation after endotoxin. J. Anim. Sci. 2008, 86:2557-2567.
201. Scammell T.E., Elmquist J.K., Griffin J.D., Saper C.B. Ventromedial preoptic prostaglandin E2 activates fever-producing autonomic pathways. J. Neurosci. 1996, 16:6246-6254.
202. Scammell T.E., Griffin J.D., Elmquist J.K., Saper C.B. Microinjection of a cyclooxygenase inhibitor into the anteroventral preoptic region attenuates LPS fever. Am. J. Physiol. 1998, 274:R783-R789.
203. Scarlett J.M., Jobst E.E., Enriori P.J., Bowe D.D., Batra A.K., Grant W.F., Cowley M.A., Marks D.L. Regulation of central melanocortin signaling by interleukin-1 beta. Endocrinology 2007, 148:4217-4225.
204. Scarlett J.M., Zhu X., Enriori P.J., Bowe D.D., Batra A.K., Levasseur P.R., Grant W.F., Meguid M.M., Cowley M.A., Marks D.L. Regulation of agouti-related protein messenger ribonucleic acid transcription and peptide secretion by acute and chronic inflammation. Endocrinology 2008, 149:4837-4845.
205. Schieferdecker H.L., Schlaf G., Jungermann K., Gotze O. Functions of anaphylatoxin C5a in rat liver: direct and indirect actions on nonparenchymal and parenchymal cells. Int. Immunopharmacol. 2001, 1:469-481.
206. Schiltz J.C., Sawchenko P.E. Distinct brain vascular cell types manifest inducible cyclooxygenase expression as a function of the strength and nature of immune insults. J. Neurosci. 2002, 22:5606-5618.
207. Schmid-Schonbein G.W. Analysis of inflammation. Annu. Rev. Biomed. Eng. 2006, 8:93-131.
208. Schwarcz R., Bruno J.P., Muchowski P.J., Wu H.Q. Kynurenines in the mammalian brain: when physiology meets pathology. Nat. Rev. Neurosci. 2012, 13:465-477.
209. Sehic E., Szekely M., Ungar A.L., Oladehin A., Blatteis C.M. Hypothalamic prostaglandin E2 during lipopolysaccharide-induced fever in guinea pigs. Brain Res. Bull. 1996, 39:391-399.
210. Seibert K., Zhang Y., Leahy K., Hauser S., Masferrer J., Isakson P. Distribution of COX-1 and COX-2 in normal and inflamed tissues. Adv. Exp. Med. Biol. 1997, 400A:167-170.
211. Setiawan E., Wilson A.A., Mizrahi R., Rusjan P.M., Miler L., Rajkowska G., Suridjan I., Kennedy J.L., Rekkas P.V., Houle S., Meyer J.H. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry 2015, 72:268-275.
212. Sharma H.S., Hoopes P.J. Hyperthermia induced pathophysiology of the central nervous system. Int. J. Hyperth. 2003, 19:325-354.
213. Shaw K.N., Commins S., O'Mara S.M. Cyclooxygenase inhibition attenuates endotoxin-induced spatial learning deficits, but not an endotoxin-induced blockade of long-term potentiation. Brain Res. 2005, 1038:231-237.
214. Shi J., Johansson J., Woodling N.S., Wang Q., Montine T.J., Andreasson K. The prostaglandin E2 E-prostanoid 4 receptor exerts anti-inflammatory effects in brain innate immunity. J. Immunol. 2010, 184:7207-7218.
215. Shie F.S., Montine K.S., Breyer R.M., Montine T.J. Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunity. Glia 2005, 52:70-77.
216. Shih R.H., Yang C.M. Induction of heme oxygenase-1 attenuates lipopolysaccharide-induced cyclooxygenase-2 expression in mouse brain endothelial cells. J. Neuroinflamm. 2010, 7:86.
217. Singh A.K., Jiang Y. How does peripheral lipopolysaccharide induce gene expression in the brain of rats?. Toxicology 2004, 201:197-207.
218. Skarnes R.C., Brown S.K., Hull S.S., McCracken J.A. Role of prostaglandin E in the biphasic fever response to endotoxin. J. Exp. Med. 1981, 154:1212-1224.
219. Skelly D.T., Hennessy E., Dansereau M.A., Cunningham C. A systematic analysis of the peripheral and CNS effects of systemic LPS, IL-1Beta, TNF-alpha and IL-6 challenges in C57BL/6 mice. PLOS ONE 2013, 8:e69123.
220. Smith A.K., Simon J.S., Gustafson E.L., Noviello S., Cubells J.F., Epstein M.P., Devlin D.J., Qiu P., Albrecht J.K., Brass C.A., Sulkowski M.S., McHutchinson J.G., Miller A.H. Association of a polymorphism in the indoleamine-2,3-dioxygenase gene and interferon-alpha-induced depression in patients with chronic hepatitis C. Mol. Psychiatry 2012, 17:781-789.
221. Starkhammar M., Kumlien Georen S., Swedin L., Dahlen S.E., Adner M., Cardell L.O. Intranasal administration of poly(I:C) and LPS in BALB/c mice induces airway hyperresponsiveness and inflammation via different pathways. PLoS ONE 2012, 7:e32110.
222. Stefferl A., Hopkins S.J., Rothwell N.J., Luheshi G.N. The role of TNF-alpha in fever: opposing actions of human and murine TNF-alpha and interactions with IL-beta in the rat. Br. J. Pharmacol. 1996, 118:1919-1924.
223. Steiner A.A., Antunes-Rodrigues J., Branco L.G. Role of preoptic second messenger systems (cAMP and cGMP) in the febrile response. Brain Res. 2002, 944:135-145.
224. Steiner A.A., Ivanov A.I., Serrats J., Hosokawa H., Phayre A.N., Robbins J.R., Roberts J.L., Kobayashi S., Matsumura K., Sawchenko P.E., Romanovsky A.A. Cellular and molecular bases of the initiation of fever. PLOS Biol. 2006, 4:e284.
225. Stone E.A., Lehmann M.L., Lin Y., Quartermain D. Depressive behavior in mice due to immune stimulation is accompanied by reduced neural activity in brain regions involved in positively motivated behavior. Biol. Psychiatry 2006, 60:803-811.
226. Stowell N.C., Seideman J., Raymond H.A., Smalley K.A., Lamb R.J., Egenolf D.D., Bugelski P.J., Murray L.A., Marsters P.A., Bunting R.A., Flavell R.A., Alexopoulou L., San Mateo L.R., Griswold D.E., Sarisky R.T., Mbow M.L., Das A.M. Long-term activation of TLR3 by poly(I:C) induces inflammation and impairs lung function in mice. Respir. Res. 2009, 10:43.
227. Streetz K.L., Wustefeld T., Klein C., Manns M.P., Trautwein C. Mediators of inflammation and acute phase response in the liver. Cell. Mol. Biol. 2001, 47:661-673.
228. Suehiro E., Fujisawa H., Ito H., Ishikawa T., Maekawa T. Brain temperature modifies glutamate neurotoxicity in vivo. J. Neurotrauma 1999, 16:285-297.
229. Swiergiel A.H., Dunn A.J. Cyclooxygenase 1 is not essential for hypophagic responses to interleukin-1 and endotoxin in mice. Pharmacol. Biochem. Behav. 2001, 69:659-663.
230. Swiergiel A.H., Dunn A.J. Distinct roles for cyclooxygenases 1 and 2 in interleukin-1-induced behavioral changes. J. Pharmacol. Exp. Ther. 2002, 302:1031-1036.
231. Swiergiel A.H., Dunn A.J. Effects of interleukin-1beta and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Pharmacol. Biochem. Behav. 2007, 86:651-659.
232. Swiergiel A.H., Smagin G.N., Johnson L.J., Dunn A.J. The role of cytokines in the behavioral responses to endotoxin and influenza virus infection in mice: effects of acute and chronic administration of the interleukin-1-receptor antagonist (IL-1ra). Brain Res. 1997, 776:96-104.
233. Takemura T., Makino S., Takao T., Asaba K., Suemaru S., Hashimoto K. Hypothalamic-pituitary-adrenocortical responses to single vs. repeated endotoxin lipopolysaccharide administration in the rat. Brain Res. 1997, 767:181-191.
234. Tanaka M., Tonouchi M., Hosono T., Nagashima K., Yanase-Fujiwara M., Kanosue K. Hypothalamic region facilitating shivering in rats. Jpn. J. Physiol. 2001, 51:625-629.
235. Tanaka M., McKinley M.J., McAllen R.M. Roles of two preoptic cell groups in tonic and febrile control of rat tail sympathetic fibers. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 296:R1248-R1257.
236. Tanaka M., McKinley M.J., McAllen R.M. Preoptic-raphe connections for thermoregulatory vasomotor control. J. Neurosci. 2011, 31:5078-5088.
237. Teeling J.L., Felton L.M., Deacon R.M., Cunningham C., Rawlins J.N., Perry V.H. Sub-pyrogenic systemic inflammation impacts on brain and behavior, independent of cytokines. Brain Behav. Immun. 2007, 21:836-850.
238. Teeling J.L., Cunningham C., Newman T.A., Perry V.H. The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: Implications for a role of COX-1. Brain Behav. Immun. 2010, 24:409-419.
239. Thornton P., McColl B.W., Cooper L., Rothwell N.J., Allan S.M. Interleukin-1 drives cerebrovascular inflammation via MAP kinase-independent pathways. Curr. Neurovasc. Res. 2010, 7:330-340.
240. Tomimoto H., Akiguchi I., Wakita H., Lin J.X., Budka H. Cyclooxygenase-2 is induced in microglia during chronic cerebral ischemia in humans. Acta Neuropathol. (Berl.) 2000, 99:26-30.
241. Turnbull A.V., Rivier C.L. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol. Rev. 1999, 79:1-71.
242. Tyring S., Gottlieb A., Papp K., Gordon K., Leonardi C., Wang A., Lalla D., Woolley M., Jahreis A., Zitnik R., Cella D., Krishnan R. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 2006, 367:29-35.
243. Udina M., Moreno-Espana J., Navines R., Gimenez D., Langohr K., Gratacos M., Capuron L., de la Torre R., Sola R., Martin-Santos R. Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms. Psychoneuroendocrinology 2013, 38:1803-1813.
244. Uehara A., Sekiya C., Takasugi Y., Namiki M., Arimura A. Anorexia induced by interleukin 1: involvement of corticotropin-releasing factor. Am. J. Physiol. 1989, 257:R613-R617.
245. Valkanova V., Ebmeier K.P., Allan C.L. CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J. Affect. Disord. 2013, 150:736-744.
246. van Dam A.M., Brouns M., Louisse S., Berkenbosch F. Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness?. Brain Res. 1992, 588:291-296.
247. van Dam A.M., Bauer J., Tilders F.J., Berkenbosch F. Endotoxin-induced appearance of immunoreactive interleukin-1 beta in ramified microglia in rat brain: a light and electron microscopic study. Neuroscience 1995, 65:815-826.
248. Venneti S., Wiley C.A., Kofler J. Imaging microglial activation during neuroinflammation and Alzheimer's disease. J. Neuroimmune Pharmacol. 2009, 4:227-243.
249. Vitkovic L., Konsman J.P., Bockaert J., Dantzer R., Homburger V., Jacque C. Cytokine signals propagate through the brain. Mol. Psychiatry 2000, 5:604-615.
250. Wan W., Wetmore L., Sorensen C.M., Greenberg A.H., Nance D.M. Neural and biochemical mediators of endotoxin and stress-induced c-fos expression in the rat brain. Brain Res. Bull. 1994, 34:7-14.
251. Wieczorek M., Swiergiel A.H., Pournajafi-Nazarloo H., Dunn A.J. Physiological and behavioral responses to interleukin-1beta and LPS in vagotomized mice. Physiol. Behav. 2005, 85:500-511.
252. Williamson L.L., Sholar P.W., Mistry R.S., Smith S.H., Bilbo S.D. Microglia and memory: modulation by early-life infection. J. Neurosci. 2011, 31:15511-15521.
253. Wilson C.J., Finch C.E., Cohen H.J. Cytokines and cognition - the case for a head-to-toe inflammatory paradigm. J. Am. Geriatr. Soc. 2002, 50:2041-2056.
254. Wu Q., Howell M.P., Cowley M.A., Palmiter R.D. Starvation after AgRP neuron ablation is independent of melanocortin signaling. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:2687-2692.
255. Yamagata K., Matsumura K., Inoue W., Shiraki T., Suzuki K., Yasuda S., Sugiura H., Cao C., Watanabe Y., Kobayashi S. Coexpression of microsomal-type prostaglandin E synthase with cyclooxygenase-2 in brain endothelial cells of rats during endotoxin-induced fever. J. Neurosci. 2001, 21:2669-2677.
256. Yamato M., Tamura Y., Eguchi A., Kume S., Miyashige Y., Nakano M., Watanabe Y., Kataoka Y. Brain interleukin-1beta and the intrinsic receptor antagonist control peripheral Toll-like receptor 3-mediated suppression of spontaneous activity in rats. PLOS ONE 2014, 9:e90950.
257. Yang H., Chen C. Cyclooxygenase-2 in synaptic signaling. Curr. Pharm. Des. 2008, 14:1443-1451.
258. Yoshida K., Hashimoto T., Sakai Y., Hashiramoto A. Involvement of the circadian rhythm and inflammatory cytokines in the pathogenesis of rheumatoid arthritis. J. Immunol. Res. 2014, 2014:282495.
259. Zaretskaia M.V., Zaretsky D.V., Shekhar A., DiMicco J.A. Chemical stimulation of the dorsomedial hypothalamus evokes non-shivering thermogenesis in anesthetized rats. Brain Res. 2002, 928:113-125.
260. Zaretskaia M.V., Zaretsky D.V., DiMicco J.A. Role of the dorsomedial hypothalamus in thermogenesis and tachycardia caused by microinjection of prostaglandin E2 into the preoptic area in anesthetized rats. Neurosci. Lett. 2003, 340:1-4.
261. Zhang H., Ching S., Chen Q., Li Q., An Y., Quan N. Localized inflammation in peripheral tissue signals the CNS for sickness response in the absence of interleukin-1 and cyclooxygenase-2 in the blood and brain. Neuroscience 2008, 157:895-907.
262. Zhu P., Genc A., Zhang X., Zhang J., Bazan N.G., Chen C. Heterogeneous expression and regulation of hippocampal prostaglandin E2 receptors. J. Neurosci. Res. 2005, 81:817-826.